Robert Spurr - Mar 2, 2022 Form 4 Insider Report for Bausch Health Companies Inc. (BHC)

Role
U.S. President-Pharma Business
Signature
/s/ Debra E. Levin, attorney-in-fact for Robert A. Spurr
Stock symbol
BHC
Transactions as of
Mar 2, 2022
Transactions value $
$823,829
Form type
4
Date filed
3/4/2022, 03:09 PM
Previous filing
Mar 2, 2022
Next filing
Mar 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BHC Common Shares, No Par Value Sale -$37.3K -1.6K -2.38% $23.37 65.4K Mar 2, 2022 Direct F1
transaction BHC Common Shares, No Par Value Award $861K +35.6K +54.48% $24.17 101K Mar 2, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BHC Non-Qualified Stock Options (right to purchase) Award $0 +132K $0.00 132K Mar 2, 2022 Common Shares, No Par Value 132K $24.17 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2021.
F2 Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc.
F3 The options vest in equal installments on each of the first three anniversaries of the date of grant.